Repros Therapeutics Inc. Announces Compliance with Nasdaq Minimum Stockholders’ Equity Requirement

THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc. (NasdaqCM:RPRX) today announced that it believes that it has regained compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market.

MORE ON THIS TOPIC